πŸ“’ Too many exams? Don’t know which one suits you best? Book Your Free Expert πŸ‘‰ call Now!

  • google app store apple app store
  • βœ–

      Question

      Which company developed the gene therapy ITVISMA for

      spinal muscular atrophy?
      A Pfizer Correct Answer Incorrect Answer
      B Roche Correct Answer Incorrect Answer
      C Novartis Correct Answer Incorrect Answer
      D AstraZeneca Correct Answer Incorrect Answer
      E Johnson & Johnson Correct Answer Incorrect Answer

      Solution

      The report mentions that ITVISMA was developed by Novartis, targeting the genetic cause of spinal muscular atrophy.

      Practice Next

      Relevant for Exams:

      ask-question